Back

Clinical features, risk factors, and prognosis of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP like regimen

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Myocardial Disease ePosters Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2020

About the speaker

Photo
Assistant Professor Takafumi Nakayama

Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan)

106 More presentations in this session

Presentation thumbnail
Comparative genetic, clinical features, and 5-years outcomes for dilated vs noncompaction cardiomyopathy
Doctor T. Vaikhanskaya (Minsk, BY)
Abstract Slides
Presentation thumbnail
Survival analysis in arrhythmogenic/dilated cardiomyopathy caused by pathogenic DSP truncating variants
Doctor A. Lamounier Junior (A Coruna, ES)
Abstract Slides
Presentation thumbnail
Clinical profiles and incident heart failure in cardiomyopathies: a population-based linked electronic health record cohort study
Doctor J. Brownrigg (Surrey, GB)
Abstract Slides
Presentation thumbnail
Two common echocardiographic variables to diagnose cardiac amyloidosis: the AMYLoidosis Index (AMYLI) score
Doctor G. Vergaro (Pisa, IT)
Abstract Slides
Presentation thumbnail
Diagnostic yield of Electroanatomic voltage mapping in guiding Endomyocardial biopsies; a comparison with an MRI-guided approach
Doctor M. Bergonti (Lugano, CH)
Abstract Slides

Access the full session

Session thumbnail
Myocardial Disease ePosters

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources